Literature DB >> 1680514

Benzodiazepine problems.

M Lader1, S Morton.   

Abstract

Benzodiazepines present problems related to both unwanted and withdrawal effects. Dosage adjustments usually obviate unwanted effects except for paradoxical reactions such as hostility. Patients with apparent benzodiazepine dependence need careful assessment with respect to personality, social situation and psychiatric disorder. The patient must be motivated and carefully prepared for withdrawal and taught anxiety management techniques. Withdrawal must always be gradual over at least 6 weeks but very prolonged schedules are counter-productive. Substituting a long-acting for a medium-acting benzodiazepine may be helpful in the more intractable cases. An antidepressant may be needed if a depressive disorder supervenes, but other adjunctive therapies are usually unhelpful.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680514     DOI: 10.1111/j.1360-0443.1991.tb01831.x

Source DB:  PubMed          Journal:  Br J Addict        ISSN: 0952-0481


  12 in total

1.  Withdrawal following sufentanil/propofol and sufentanil/midazolam. Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids.

Authors:  Maria Korak-Leiter; Rudolf Likar; Michael Oher; Ernst Trampitsch; Gerda Ziervogel; Joseph V Levy; Enno C Freye
Journal:  Intensive Care Med       Date:  2005-02-16       Impact factor: 17.440

2.  Precipitated withdrawal in squirrel monkeys after repeated daily oral administration of alprazolam, diazepam, flunitrazepam or oxazepam.

Authors:  J R Martin; J L Moreau; F Jenck
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

3.  Anti-anxiety activity of Coriandrum sativum assessed using different experimental anxiety models.

Authors:  Poonam Mahendra; Shradha Bisht
Journal:  Indian J Pharmacol       Date:  2011-09       Impact factor: 1.200

4.  Evaluation of anxiolytic activity of aqueous extract of Coriandrum sativum Linn. in mice: A preliminary experimental study.

Authors:  K Latha; B Rammohan; B P V Sunanda; M S Uma Maheswari; Surapaneni Krishna Mohan
Journal:  Pharmacognosy Res       Date:  2015-06

5.  Evaluation of anxiolytic activity of methanolic extract of Urtica urens in a mice model.

Authors:  Zouhra Doukkali; Khalid Taghzouti; E L Houcine Bouidida; Mohamed Nadjmouddine; Yahya Cherrah; Katim Alaoui
Journal:  Behav Brain Funct       Date:  2015-04-24       Impact factor: 3.759

6.  Investigating the effect of hydro-alcoholic extract of Salix aegyptiaca on anxiety in male rat.

Authors:  Alireza Komaki; Nasrin Hashemi-Firouzi; Sahar Kakaei; Siamak Shahidi; Abdolrahman Sarihi; Iraj Salehi
Journal:  Adv Biomed Res       Date:  2015-11-30

7.  Anxiolytic activity of aqueous extract of Camellia sinensis in rats.

Authors:  Rajeshwari Shastry; Sheetal Dinkar Ullal; Shreyas Karkala; Seema Rai; Akash Gadgade
Journal:  Indian J Pharmacol       Date:  2016 Nov-Dec       Impact factor: 1.200

8.  Evaluation of anxiolytic activity of compound Valeriana jatamansi Jones in mice.

Authors:  Jie-Shu You; Min Peng; Jin-Li Shi; Hu-Zhan Zheng; Yong Liu; Bao-Sheng Zhao; Jian-You Guo
Journal:  BMC Complement Altern Med       Date:  2012-11-21       Impact factor: 3.659

Review 9.  Sinapic Acid and Its Derivatives as Medicine in Oxidative Stress-Induced Diseases and Aging.

Authors:  Chunye Chen
Journal:  Oxid Med Cell Longev       Date:  2015-11-10       Impact factor: 6.543

10.  Evaluation of anxiolytic-like activity of Vitis vinifera juice in mice.

Authors:  Muhammad Aslam; Nuzhat Sultana
Journal:  Avicenna J Phytomed       Date:  2016 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.